Ibio Financials

IBIO Stock  USD 3.43  0.17  4.72%   
Based on the analysis of Ibio's profitability, liquidity, and operating efficiency, Ibio Inc is not in a good financial situation at this time. It has a very high odds of going through financial crisis in March.
  
Understanding current and past Ibio Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Ibio's financial statements are interrelated, with each one affecting the others. For example, an increase in Ibio's assets may result in an increase in income on the income statement.

Ibio Stock Summary

Ibio competes with Jaguar Animal, GeoVax Labs, Ocugen, Tonix Pharmaceuticals, and Sonnet Biotherapeutics. iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company was incorporated in 2008 and is headquartered in Bryan, Texas. Ibio operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 105 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNYSE MKT Exchange
ISINUS4510332038
CUSIP451033203 451033104 451033609 451033708 45107K102
LocationNew York; U.S.A
Business Address11750 Sorrento Valley
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websiteibioinc.com
Phone979 446 0027
CurrencyUSD - US Dollar

Ibio Key Financial Ratios

Ibio Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Ibio's current stock value. Our valuation model uses many indicators to compare Ibio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ibio competition to find correlations between indicators driving Ibio's intrinsic value. More Info.
Ibio Inc is rated fourth overall in return on equity category among its peers. It also is rated fourth overall in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ibio's earnings, one of the primary drivers of an investment's value.

Ibio Inc Systematic Risk

Ibio's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Ibio volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-one with a total number of output elements of fourty. The Beta measures systematic risk based on how returns on Ibio Inc correlated with the market. If Beta is less than 0 Ibio generally moves in the opposite direction as compared to the market. If Ibio Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Ibio Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Ibio is generally in the same direction as the market. If Beta > 1 Ibio moves generally in the same direction as, but more than the movement of the benchmark.

Ibio February 17, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Ibio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ibio Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ibio Inc based on widely used predictive technical indicators. In general, we focus on analyzing Ibio Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ibio's daily price indicators and compare them against related drivers.
When determining whether Ibio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ibio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ibio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ibio Inc Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ibio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ibio. If investors know Ibio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ibio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Ibio Inc is measured differently than its book value, which is the value of Ibio that is recorded on the company's balance sheet. Investors also form their own opinion of Ibio's value that differs from its market value or its book value, called intrinsic value, which is Ibio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ibio's market value can be influenced by many factors that don't directly affect Ibio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ibio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ibio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ibio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.